Voxel-wise analysis: A powerful tool to predict radio-induced toxicity and potentially perform personalised planning in radiotherapy.

Prediction Prédiction Radio-induced toxicity Toxicité radio-induite Voxel Voxel-wise analysis

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 22 06 2023
accepted: 27 06 2023
medline: 12 9 2023
pubmed: 31 7 2023
entrez: 30 7 2023
Statut: ppublish

Résumé

Dose - volume histograms have been historically used to study the relationship between the planned radiation dose and healthy tissue damage. However, this approach considers neither spatial information nor heterogenous radiosensitivity within organs at risk, depending on the tissue. Recently, voxel-wise analyses have emerged in the literature as powerful tools to fully exploit three-dimensional information from the planned dose distribution. They allow to identify anatomical subregions of one or several organs in which the irradiation dose is associated with a given toxicity. These methods rely on an accurate anatomical alignment, usually obtained by means of a non-rigid registration. Once the different anatomies are spatially normalised, correlations between the three-dimensional dose and a given toxicity can be explored voxel-wise. Parametric or non-parametric statistical tests can be performed on every voxel to identify the voxels in which the dose is significantly different between patients presenting or not toxicity. Several anatomical subregions associated with genitourinary, gastrointestinal, cardiac, pulmonary or haematological toxicity have already been identified in the literature for prostate, head and neck or thorax irradiation. Voxel-wise analysis appears therefore first particularly interesting to increase toxicity prediction capability by identifying specific subregions in the organs at risk whose irradiation is highly predictive of specific toxicity. The second interest is potentially to decrease the radio-induced toxicity by limiting the dose in the predictive subregions, while not decreasing the dose in the target volume. Limitations of the approach have been pointed out.

Identifiants

pubmed: 37517974
pii: S1278-3218(23)00139-7
doi: 10.1016/j.canrad.2023.06.024
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

638-642

Informations de copyright

Copyright © 2023 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

C Sosa-Marrero (C)

Université de Rennes, CLCC Eugène-Marquis, Inserm, LTSI - UMR 1099, 35000 Rennes, France.

O Acosta (O)

Université de Rennes, CLCC Eugène-Marquis, Inserm, LTSI - UMR 1099, 35000 Rennes, France.

D Pasquier (D)

Radiotherapy Department, centre Oscar-Lambret, 59000 Lille, France; Université de Lille, CNRS, école centrale de Lille, Cristal UMR 9189, Lille, France.

J Thariat (J)

Department of Radiation Oncology, centre François-Baclesse, 14000 Caen, France.

G Delpon (G)

Medical physics department, institut de cancérologie de l'Ouest, IMT Atlantique, Nantes université, CNRS/IN2P3, Subatech, Nantes, France.

C Fiorino (C)

Medical Physics, San Raffaele Scientific Institute, Via Olgettina 690, 20132 Milan, Italy.

T Rancatti (T)

Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

O Malard (O)

Service de chirurgie oto-rhinolaryngologique (ORL) et chirurgie cervicofaciale, Hôtel-Dieu, CHU de Nantes, Nantes, France.

N Foray (N)

Centre Léon-Bérard, Inserm U1296 "Radiation: Defense/Health/Environment", 69008 Lyon, France.

R de Crevoisier (R)

Université de Rennes, CLCC Eugène-Marquis, Inserm, LTSI - UMR 1099, 35000 Rennes, France; Département de radiothérapie, centre Eugène-Marquis, 35000 Rennes, France. Electronic address: r.de-crevoisier@rennes.unicancer.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH